Drug: endoxan Quarter: 2016Q3
Total Drug/Injury Combinations: 404 Number of Pages: 21
| DRUGNAME | PT | EventCount | |
|---|---|---|---|
| ENDOXAN 1000 MG, POUDRE POUR SOLUTION INJECTABLE | Diarrhoea | 7 | view events |
| Endoxan 500mg inj. (cyclophosphamide) | Diffuse large B-cell lymphoma refractory | 7 | view events |
| Endoxan 500mg inj. (cyclophosphamide) | Disease progression | 7 | view events |
| ENDOXAN | Cough | 6 | view events |
| ENDOXAN | Cytomegalovirus viraemia | 6 | view events |
| ENDOXAN | Off label use | 6 | view events |
| ENDOXAN | Pneumonia | 6 | view events |
| ENDOXAN 1000 MG, POUDRE POUR SOLUTION INJECTABLE | Febrile neutropenia | 6 | view events |
| ENDOXAN 1000 MG, POUDRE POUR SOLUTION INJECTABLE | Lung consolidation | 6 | view events |
| ENDOXAN | Abdominal pain | 5 | view events |
| ENDOXAN | Anaemia | 5 | view events |
| ENDOXAN | Bacterial infection | 5 | view events |
| Endoxan | Cardiomyopathy | 5 | view events |
| ENDOXAN | Cytomegalovirus test positive | 5 | view events |
| ENDOXAN | Febrile bone marrow aplasia | 5 | view events |
| ENDOXAN | Malignant neoplasm progression | 5 | view events |
| ENDOXAN | Septic shock | 5 | view events |
| ENDOXAN | Stomatitis | 5 | view events |
| ENDOXAN /00021101/ | Acute myeloid leukaemia | 5 | view events |
| ENDOXAN /00021101/ | Second primary malignancy | 5 | view events |
Total Drug/Injury Combinations: 404 Number of Pages: 21
NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)